By taking part in research you’ll be helping us to test and developed things like new models of care, support methods and drug treatments.
By taking part in research you’ll be helping us to test and developed things like new models of care, support methods and drug treatments.
All of the studies you see below have been given approval by the Health Research Authority and will be carried out by experts with clinical, research and academic backgrounds.
Who this study is aimed at?
Adults aged 16 or older with a diagnosis of ASD
Who can’t take part?
People who do not have a confirmed diagnosis of ASD
Study summary
Questionnaire for people to be included in a cohort so that researchers can learn about the lives of adults on the autism spectrum
Study visits
One off questionnaire. Participants may be contacted in the future to be asked if they would like to take part in autism-related studies.
Services taking part
Autism Service, Michael Carlisle Centre
Who to contact
See website here.
How to contact
See website above.
Who this study is aimed at?
People who take opioid drugs such as heroin, morphine, fentanyl and methadone, and people who are friends or family members of a person at risk of opioid overdose
Who can’t take part?
Drug service users (or friends and family members of service users) who have no experience of opioid misuse
Study summary
One off interview lasting about 30-45 minutes or one off focus group lasting about 60 minutes
Study visits
One
Services taking part
Fitzwilliam Centre
Who to contact
Zoe Black
How to contact
Who this study is aimed at?
People who have symptoms of depression or non-psychotic low mood with a duration of illness of at least 2 years and are receiving treatment from an NHS mental health service with regular contact with clinicians
Who can’t take part?
People who have a primary diagnosis of a substance misuse problem, a diagnosis of a mental disorder eg Alzheimer’s, current inpatients on a psychiatric ward. People who do not currently have clinical contact with a mental health professional
Study summary
This research aims to develop a new approach to help people with chronic depression. Researchers have developed an intervention called “DIALOG+” which helped people with schizophrenia. DIALOG+ involved mental health staff using a tablet computer to ask about satisfaction with different areas of life and then working together to find solutions to concerns raised. After using DIALOG+, service users were more satisfied with life and had fewer symptoms. Service users and staff found the approach helpful and it saved the NHS money.
The second phase of the TACK programme is looking at the effectiveness of DIALOG+ for people with chronic depression on improving quality of life and clinical outcomes (such as depression symptoms). The intervention will be tested in routine meetings across six sites in England. Researchers will also evaluate how cost-effective the intervention is within the NHS. They will also determine what works well or not so well in order to improve training materials and resources for staff.
Study visits
Six months of monthly sessions, followed by six months of booster sessions, to be done at the same time as clinical appointments
Services taking part
Northlands Community Health Centre, Edmund Road, East Glade Centre
Who to contact
Matthew Mills, Shonagh Scott, Jonathan Woods
How to contact
matthew.mills@shsc.nhs.uk, shonagh.scott@shsc.nhs.uk jonathan.woods@shsc.nhs.uk
Find out more
Find out more information here.
Who this study is aimed at?
Service users aged 18-70 with symptoms of psychosis for longer than two weeks but less than two years
Who can’t take part?
Service users who have had psychotic symptoms for longer than two years
Study summary
Staff will collect a small sample of blood from you and other people with psychosis symptoms from across the country. They will also collect some information about your symptoms and background. If your blood test then shows that your immune system is not working properly they will discuss this with you. Researchers are exploring a possible treatment in a separate study called SINAPPS2 and you may be able to take part in this study.
Study visits
One visit of approximately 15 minutes
Services taking part
Limbrick Health Centre
Who to contact
Dr Raihan Talukdar, Alex Carey
How to contact
raihan.talukdar@shsc.nhs.uk, alex.carey@shsc.nhs.uk
Find out more
Find out more information here.
Who this study is aimed at?
Adults who have previously been admitted to an acute mental health ward. Friends or relatives of these adults, who are willing to share further information with consent.
Who can’t take part?
Exclusion criteria include patients under the age of 18 years, over the age of 65 years and/or having no history of being a psychiatric inpatient.
Study summary
There has been little research into how common problems with social communication are in people who have been admitted to mental health wards, as well as their physical and mental health needs.
A research team at the University of Leicester has launched a study to learn more about these issues.
Study visits
The study will involve completion of autism-based questionnaire tests and an interview process
Services taking part
Limbrick Health Centre
Who to contact
Study Co-ordinator Hannah Gower
How to contact
Tel: 0114 2716315
Email: hannah.gower@shsc.nhs.uk
Who this study is aimed at?
Study summary
Hearing voices is one of the most common symptoms of schizophrenia. We aim to learn why some patients listen to and believe the content of distressing voices. This will enable the later development of psychological therapies which enable patients to disengage from distressing voice content.
Study visits
Services taking part
Limbrick Health Centre
Who to contact
Dr Andrew Horan, Local Principal Investigator, Recovery Service North
How to contact
Email: Andrew.Horan@shsc.nhs.uk
Tel: 0114 271 6217
Who this study is aimed at?
You can take part if you are 16 years and over and have heard voices for at least six months. We would like to invite the following groups of people to take part: people who have and have not had psychological therapy in the past, people who do and do not have a mental health diagnosis.
Study summary
There are lots of different types of psychological (talking) therapies for the experience of hearing distressing voices. However, there hasn’t been any research about patient preferences for these therapies. We would like to find out more about your preferences, for example:
We want to be able to publish this information in scientific and healthcare journals and conferences. This will help clinicians and researchers to develop and offer therapies that better match with the patients’ preferences.
Study visits
The study involves completing some questionnaires. These will include questions:
Who to contact
Research Development Unit
How to contact
Who this study is aimed at?
Patients with a diagnosis of Alzheimer’s disease between the age of 50 to 90
Study summary
Many people may find their memory changes as they age. For most, it is a natural part of aging. For some however, it could be an indication of something more serious. For some, it could be Alzheimer’s Disease.
St Pancras Clinical Research is conducting a trial of an investigational drug for early stage Alzheimer’s, if you would like more information, please contact St Pancras Clinical Research at www.stpancrasclinicalresearch.com
Services taking part
Memory Service
Who to contact
Amanda Bennett, Research Nurse
How to contact
Who is this study aimed at ?
All staff, students and volunteers working at SHSC NHS FT
Study Summary
NHS Check is an independent research study, supported by the NHS. Your input will help us to understand how to better support you and your colleagues during and after the COVID-19 pandemic.
It only takes 5-10 minutes to complete a confidential survey
How can I take part ?
Take part online www.nhscheck.org
Who is this study aimed at ?
Any patient referred to Sheffield Memory Clinic with a suspected diagnosis, any patient who has experienced a suspected stoke, any patient under review by a neurologist for a suspected movement disorder and any healthy volunteer over 18.
Who can't take part ?
People who lack capacity to give informed consent, People who are unable to communicate and understand written or spoken English, people with very impaired speech production and people with severe motor impairment that means they can not respond to questions
Study Summary
The aim of the study is to understand whether patients can talk to a computerised doctor (CognoSpeak) regarding their neurological health. CognoSpeak is a computerised person i.e. a human looking computer generated image that will ask the participant questions regarding their health. The answers will be analysed by a person or computer to look for features of speech and interaction seen in dementia or other memory disorders. This study will also use healthy people to speak to CognoSpeak, so the study team can compare data to a group with no cognitive complaints.
Study Visits
The initial visit will be followed up with further visits at 6 month, 12 month and 24 month intervals, each taking approx. 1 hour
Who to contact
Dr Aparna Mordekar at Sheffield Memory Service
Tel: 0114 22661696
E: Aparna.mordekar@shsc.nhs.uk
Who is this study aimed at?
People aged over 18 years, have a diagnosis of SMI and previously participated in the Health & Wellbeing Study and consented to be re-contacted
Who can't take part
People who lack mental capacity to give consent
Study summary
To explore how people with SMI experience the current pandemic restrictions and their social consequences. We will explore the ability of people with SMI access both primary care and mental health services and how they utilise digital media and the internet. Whether they experience feelings of social isolation and loneliness and if they have changed their health-related behaviour to reduce the risk of COVID-19
Who to contact
Alex Carey Tel No 0114 2718070 email alex.carey@shsc.nhs.uk
Who is this study aimed at ?
People over 18, who have attended A&E, a GP's surgery or a mental health service in the past 8 weeks due to self-harm including drug overdoses, which has been at least their 3rd self-harm episode in the previous 12 months.
Have mental capacity to provide fully informed written consent.
Who can't take part
People who lack mental capacity
Who are receiving a specific psychological intervention for a related condition (eg anorexia or drug addiction)
Insufficient English language to contribute
Refusal to provide fully informed written consent
People with a known risk of violence
Study summary
To improve the quality of life of people who repeatedly self-harm, our approach involves modifying three existing therapies, that can be adapted to deliver a new therapeutic approach for people who self-harm, and are accessible to large numbers of people who repeatedly self-harm and are seen in mainstream NHS practices.
Who to contact
Alex Carey Tel No 0114 2718070 email alex.carey@shsc.nhs.uk
Dr Abhijeeth Shetty Tel 0114 271209 email abhijeeth.shetty@shsc.nhs.uk
Who is this study aimed at ?
Any individual over the age 16
Who can't take part?
Those unwilling or lacking capacity to participate
Study summary
This study aims to investigate and explore the psychological impact of COVID-19 the resultant restrictions and impact on behaviours and changes in mental wellbeing across the global population
For further information
Who this study is aimed at?
Service users who have experienced being an inpatient in hospital and who smoke or who have given up smoking in the last few years.
Study summary
Researchers are looking for your opinions on what would be helpful to be included in an intervention to help people stay smoke-free after they are discharged from hospital.
Study visits
There is a service user research consultation session taking place on Wednesday 27 January from 2pm to 3.30pm.
The session will last about an hour and will be facilitated by researchers from the University of York. You will take part in a group discussion about your experiences with smoking, stopping smoking and what would be helpful.
You can join the meeting on Microsoft Teams here.
Who to contact
Ellie Wildbore, Patient Ambassador – Medical Education and Research
How to contact